
[TimAlerts] $SGYP initiates second Phase 3 study of plecanatide in IBS-C; shares rise 4% premarket http://seekingalpha.com/news/2594685-synergy-pharma-initiates-second-phase-3-study-of-plecanatide-in-ibs-c-shares-rise-4-percent-premarket?app=1&uprof=82&dr=1#email_link
